SEC Form 4 · accession 0000899243-17-008507
CYNOSURE INC · CYNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen J. Webber
Officer — Chief Financial Officer
Period of report
Mar 22, 2017
Accepted (ET)
Mar 24, 2017 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Mar 22, 2017 | A | 23,180 | — | A | 23,180 | D | |
| Class A Common StockF1 | Mar 22, 2017 | D | 23,180 | — | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F2 | — | Mar 22, 2017 | D | 10,000 | D | — | Oct 10, 2026 | Class A Common Stock | 10,000 | 0 | D |
| Restricted Stock UnitsF3,F2 | — | Mar 22, 2017 | D | 9,483 | D | — | Feb 8, 2027 | Class A Common Stock | 9,483 | 0 | D |
Explanation of responses
- F1Represents unvested performance-based share units that became vested and were converted in the Merger (all terms capitalized but not defined shall have the meaning given to them in that certain Agreement and Plan of Merger, dated as of February 14, 2017, by and among Hologic, Inc., Minuteman Merger Sub, Inc. and Cynosure, Inc. (the "Merger Agreement")) into the right to receive $66.00 per share, net to the seller in cash, without interest, less any required withholding taxes (the "Merger Consideration"). Pursuant to the terms of the Merger Agreement, each outstanding and unvested performance-based share unit as of immediately prior to the Effective Time vested with respect to the maximum number of shares that could be earned thereunder and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share.
- F2Each restricted stock unit represents a contingent right to receive one share of Cynosure, Inc.'s common stock.
- F3Pursuant to the terms of the Merger Agreement, each outstanding and unvested restricted stock unit as of immediately prior to the Effective Time vested in full and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share.